Literature DB >> 15767439

TFII-I regulates induction of chromosomally integrated human immunodeficiency virus type 1 long terminal repeat in cooperation with USF.

Jiguo Chen1, Tom Malcolm, Mario C Estable, Robert G Roeder, Ivan Sadowski.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) replication is coupled to T-cell activation through its dependence on host cell transcription factors. Despite the enormous sequence variability of these factors, several cis elements for host factors are highly conserved within the 5' long terminal repeats (LTRs) of viruses from AIDS patients; among these is the RBEIII upstream element for the Ras response element binding factor 2 (RBF-2). Here we show that RBF-2 is comprised of a USF1/USF2 heterodimer and TFII-I, which bind cooperatively to RBEIII. Recombinant USF1/USF2 binds to the RBEIII core sequence 160-fold less efficiently than it binds to an E box element, but the interaction with RBEIII is stimulated by TFII-I. Chromosomally integrated HIV-1 LTRs bearing an RBEIII mutation have slightly elevated basal transcription in unstimulated Jurkat cells but are unresponsive to cross-linking of the T-cell receptor or stimulation with phorbol myristate acetate (PMA) and ionomycin. Induction is inhibited by dominant interfering USF and TFII-I but not by the dominant negative I-kappaB protein. USF1, USF2, and TFII-I bind to the integrated wild-type LTR in unstimulated cells and become phosphorylated during the induction of transcription upon stimulation with PMA. These results demonstrate that USF1/USF2 and TFII-I interact cooperatively at the upstream RBEIII element and are necessary for the induction of latent HIV-1 in response to T-cell activation signals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15767439      PMCID: PMC1061576          DOI: 10.1128/JVI.79.7.4396-4406.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity.

Authors:  M C Estable; B Bell; A Merzouki; J S Montaner; M V O'Shaughnessy; I J Sadowski
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

2.  Functional domains of the transcription factor USF2: atypical nuclear localization signals and context-dependent transcriptional activation domains.

Authors:  X Luo; M Sawadogo
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

3.  Ras-responsiveness of the HIV-1 LTR requires RBF-1 and RBF-2 binding sites.

Authors:  B Bell; I Sadowski
Journal:  Oncogene       Date:  1996-12-19       Impact factor: 9.867

4.  DNA-binding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation.

Authors:  E Cheung; P Mayr; F Coda-Zabetta; P G Woodman; D S Boam
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

5.  Cloning of an inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1.

Authors:  A L Roy; H Du; P D Gregor; C D Novina; E Martinez; R G Roeder
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

6.  Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit.

Authors:  T A Bird; K Schooley; S K Dower; H Hagen; G D Virca
Journal:  J Biol Chem       Date:  1997-12-19       Impact factor: 5.157

7.  Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

Authors:  D J Van Antwerp; S J Martin; T Kafri; D R Green; I M Verma
Journal:  Science       Date:  1996-11-01       Impact factor: 47.728

8.  Identification of a replication-competent pathogenic human immunodeficiency virus type 1 with a duplication in the TCF-1alpha region but lacking NF-kappaB binding sites.

Authors:  L Zhang; Y Huang; H Yuan; B K Chen; J Ip; D D Ho
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

9.  Cooperative interaction of ets-1 with USF-1 required for HIV-1 enhancer activity in T cells.

Authors:  M H Sieweke; H Tekotte; U Jarosch; T Graf
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

10.  The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.

Authors:  T K Archer; E Zaniewski; M L Moyer; S K Nordeen
Journal:  Mol Endocrinol       Date:  1994-09
View more
  22 in total

1.  Identification of cellular proteins required for replication of human immunodeficiency virus type 1.

Authors:  Natallia Dziuba; Monique R Ferguson; William A O'Brien; Anthony Sanchez; Andrew J Prussia; Natalie J McDonald; Brian M Friedrich; Guangyu Li; Michael W Shaw; Jinsong Sheng; Thomas W Hodge; Donald H Rubin; James L Murray
Journal:  AIDS Res Hum Retroviruses       Date:  2012-04-20       Impact factor: 2.205

2.  Identification and functional analysis of a second RBF-2 binding site within the HIV-1 promoter.

Authors:  Matthew S Dahabieh; Marcel Ooms; Tom Malcolm; Viviana Simon; Ivan Sadowski
Journal:  Virology       Date:  2011-08-02       Impact factor: 3.616

3.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

Review 4.  Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later.

Authors:  Ananda L Roy
Journal:  Gene       Date:  2011-10-21       Impact factor: 3.688

Review 5.  The contribution of GTF2I haploinsufficiency to Williams syndrome.

Authors:  Thanathom Chailangkarn; Chalongrat Noree; Alysson R Muotri
Journal:  Mol Cell Probes       Date:  2018-01-03       Impact factor: 2.365

Review 6.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

7.  Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence.

Authors:  Thórdur Oskarsson; Hulda S Hreggvidsdóttir; Gudrún Agnarsdóttir; Sigrídur Matthíasdóttir; Margrét H Ogmundsdóttir; Stefán R Jónsson; Gudmundur Georgsson; Sigurdur Ingvarsson; Olafur S Andrésson; Valgerdur Andrésdóttir
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

8.  Characterization of a novel interaction between transcription factor TFII-I and the inducible tyrosine kinase in T cells.

Authors:  Catarina Sacristán; Stefan A Schattgen; Leslie J Berg; Stephen C Bunnell; Ananda L Roy; Yvonne Rosenstein
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

9.  PKC-dependent stimulation of the human MCT1 promoter involves transcription factor AP2.

Authors:  Seema Saksena; Alka Dwivedi; Ravinder K Gill; Amika Singla; Waddah A Alrefai; Jaleh Malakooti; Krishnamurthy Ramaswamy; Pradeep K Dudeja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-11-25       Impact factor: 4.052

10.  IL-2-inducible T-cell kinase (ITK) finds another (dance) partner...TFII-I.

Authors:  Avery August
Journal:  Eur J Immunol       Date:  2009-09       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.